Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide reduces appetite by slowing stomach emptying and activating brain regions that control hunger, making it easier to eat smaller portions of foods you enjoy—including potatoes. Many people wonder whether specific carbohydrates are off-limits during GLP-1 therapy, and the answer is more nuanced than simple restriction.
How Semaglutide Changes Your Relationship with Carbohydrates
Semaglutide works by mimicking glucagon-like peptide-1, a natural hormone that regulates blood sugar and satiety signals. When taking semaglutide, patients typically experience reduced cravings and feel satisfied with smaller meal volumes, which naturally limits how much of any food—including potatoes—they consume. This physiological shift means you're not fighting willpower; your body's appetite signals are genuinely dampened.
The medication doesn't prevent you from eating carbohydrates; rather, it changes how your body processes hunger and fullness cues. Many semaglutide patients report that they can eat foods they previously craved, but stop eating much sooner because they feel full. This mechanism allows flexibility in food choices while supporting sustainable weight loss.
Potato Portions and Blood Sugar Impact on GLP-1 Therapy
White and russet potatoes have a high glycemic index, meaning they raise blood sugar quickly. However, semaglutide slows gastric emptying—the rate at which food moves from your stomach into your small intestine—which moderates blood sugar spikes even after high-glycemic foods. This doesn't mean unlimited consumption, but rather that reasonable portions of potatoes are compatible with semaglutide therapy when paired with protein and non-starchy vegetables.
Preparation method significantly affects glycemic response. Baked, boiled, or air-fried potatoes with skin intact contain more fiber and nutrients than mashed or fried versions. Adding a protein source like grilled chicken, salmon, or Greek yogurt creates a more balanced meal that slows glucose absorption further. Most semaglutide patients find success with a ½-cup to 1-cup portion of prepared potatoes per meal, down from their previous intake.
Best Potato Choices While Taking Semaglutide
Sweet potatoes and red potatoes are superior choices compared to white potatoes because they contain more fiber and have a lower glycemic index. Sweet potatoes provide beta-carotene and additional micronutrients that support metabolic health, while red potatoes with skin contain resistant starch, a type of carbohydrate that behaves differently in the body than regular starch. Both options pair well with semaglutide's appetite-suppressing effects without causing dramatic blood sugar fluctuations.
Cold potatoes—such as potato salad made with vinegar-based dressing—have a lower glycemic index than hot potatoes because cooling changes the starch structure into resistant starch. This simple preparation hack allows you to enjoy larger portions of potatoes while minimizing blood sugar impact. Adding mustard, vinegar, or lemon juice further reduces glycemic response by up to 30%, according to metabolic research.
Personalizing Your Semaglutide Diet Plan with Genetic Insights
Individual responses to carbohydrates vary based on genetic predispositions affecting glucose metabolism and satiety hormone sensitivity. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 metabolic pathways and 49 peptides to reveal how your body responds to different macronutrient compositions. Key variants in the GLP1R and FTO genes, for example, influence how effectively semaglutide suppresses your appetite and how your body processes carbohydrate-rich foods like potatoes.
Understanding your genetic profile helps your PlexusDx provider personalize not just your semaglutide dose, but also your dietary recommendations. Some patients may thrive with moderate potato intake, while others with specific genetic variants benefit from limiting starchy carbohydrates more strictly. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of semaglutide treatment, providing actionable nutrition guidance tailored to your biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I eat french fries or potato chips while taking semaglutide?
Fried potatoes are higher in calories and lack the fiber of whole potatoes, making them less compatible with semaglutide's appetite control mechanism. Most patients find they naturally lose interest in fried foods on semaglutide because the medication reduces cravings for high-fat, processed items.
Will eating potatoes prevent weight loss on semaglutide?
Potatoes alone do not prevent weight loss if portions are reasonable and balanced with protein and vegetables. Clinical data shows semaglutide patients lose significant weight even when including carbohydrates, because the medication's appetite suppression naturally reduces total calorie intake.
How much does semaglutide cost at PlexusDx, and does it cover dietary counseling?
PlexusDx compounded semaglutide injections start at $149 per month, with no insurance required and HSA/FSA eligibility. Your dose may need to go up; your price won't.
Are there any side effects from eating potatoes while on semaglutide?
Potatoes themselves don't cause semaglutide side effects; however, large meals or rapid eating can trigger nausea or gastroparesis-like symptoms in some patients. Eating slowly, in smaller portions, and chewing thoroughly—strategies naturally supported by semaglutide's appetite suppression—prevents these issues.
How do genetic variants affect how my body handles potato carbohydrates on semaglutide?
The PlexusDx Precision Peptide Genetic Test evaluates variants like GLP1R rs6923761 and FTO rs9939609, which influence carbohydrate metabolism and satiety signaling. Patients with specific FTO variants may benefit from slightly lower starch intake, while those with favorable GLP1R variants often tolerate moderate potato consumption well.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Optimizing Your Weight Loss Journey: What Time of Day Should I Take Tirzepatide?
GLP-1 Medications and Cholesterol: What to Expect in Your Labs